scholarly article | Q13442814 |
P356 | DOI | 10.1177/2047487315598711 |
P698 | PubMed publication ID | 26232281 |
P50 | author | Steven Nissen | Q7615086 |
Samir Kapadia | Q87699930 | ||
E. Murat Tuzcu | Q108198403 | ||
Stephen Nicholls | Q73438504 | ||
Bhanu Duggal | Q83533227 | ||
P2093 | author name string | Kiyoko Uno | |
Rishi Puri | |||
Yu Kataoka | |||
Muhammad Hammadah | |||
P2860 | cites work | Epidemiologic and economic consequences of the global epidemics of obesity and diabetes | Q22251061 |
Concept of vulnerable/unstable plaque | Q27687028 | ||
Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study | Q28280445 | ||
Prevalence and trends in obesity among US adults, 1999-2008 | Q29547759 | ||
Optical coherence tomography | Q29617481 | ||
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials | Q29617910 | ||
Comprehensive volumetric optical microscopy in vivo | Q30488753 | ||
Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction | Q34216019 | ||
Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation | Q34261694 | ||
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial | Q34501729 | ||
Update on acute coronary syndromes: the pathologists' view | Q34646452 | ||
Inflammation, insulin resistance, and obesity. | Q35918777 | ||
Adipose tissue, inflammation, and cardiovascular disease | Q36125401 | ||
Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue | Q36141342 | ||
Abdominal obesity and metabolic syndrome | Q36682671 | ||
International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries | Q36777590 | ||
Adipokines as emerging mediators of immune response and inflammation. | Q37014112 | ||
Effect of obesity on coronary atherosclerosis and outcomes of percutaneous coronary intervention: grayscale and virtual histology intravascular ultrasound substudy of assessment of dual antiplatelet therapy with drug-eluting stents | Q38418337 | ||
Adiponectin, type 2 diabetes and cardiovascular risk | Q44240418 | ||
Association of hypoadiponectinemia with impaired vasoreactivity | Q44513155 | ||
Adiponectin stimulates production of nitric oxide in vascular endothelial cells. | Q44565932 | ||
Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial | Q44783935 | ||
Intensive lipid lowering with atorvastatin in patients with stable coronary disease | Q45310626 | ||
Disturbed adiponectin – AMPK system in skeletal muscle of patients with metabolic syndrome. | Q46178402 | ||
Adiponectin inhibits endothelial synthesis of interleukin-8. | Q46790564 | ||
Association between plasma high-molecular-weight adiponectin and coronary plaque characteristics assessed by computed tomography angiography in conditions of visceral adipose accumulation | Q47315959 | ||
Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages | Q47735588 | ||
Low plasma adiponectin levels are associated with presence of thin-cap fibroatheroma in men with stable coronary artery disease | Q47917029 | ||
Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology | Q48575894 | ||
Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. | Q52545341 | ||
Effects of Obesity on Lipid-Lowering, Anti-Inflammatory, and Antiatherosclerotic Benefits of Atorvastatin or Pravastatin in Patients With Coronary Artery Disease (from the REVERSAL Study) | Q57740273 | ||
P433 | issue | 10 | |
P921 | main subject | obesity | Q12174 |
coronary artery disease | Q844935 | ||
P304 | page(s) | 1331-1339 | |
P577 | publication date | 2015-07-31 | |
P1433 | published in | European Journal of Preventive Cardiology | Q2493290 |
P1476 | title | Plaque vulnerability at non-culprit lesions in obese patients with coronary artery disease: Frequency-domain optical coherence tomography analysis. | |
P478 | volume | 22 |
Q52675560 | Adipose-Derived Exosomes Exert Proatherogenic Effects by Regulating Macrophage Foam Cell Formation and Polarization. |
Q33567290 | Lipid Lowering Therapy to Modify Plaque Microstructures. |
Q46445382 | Omentin concentrations are independently associated with those of matrix metalloproteinase-3 in patients with mild but not severe rheumatoid arthritis |
Q35997013 | Outcome after Elective Percutaneous Coronary Intervention Depends on Age in Patients with Stable Coronary Artery Disease - An Analysis of Relative Survival in a Multicenter Cohort and an OCT Substudy |
Search more.